FDA Recommends Resuming Use of Rotarix® and Continuing Use of RotaTeq®
On May 14, 2010, the U.S. Food and Drug Administration revised its recommendations for rotavirus vaccines for the prevention of the disease in infants and has determined that it is appropriate for clinicians and healthcare professionals to resume the use of Rotarix® and to continue the use of RotaTeq®. Read the full article »

Cases of Whooping Cough More Than Double in California
Four newborns have died from the disease - two in Los Angeles County and two in the Central Valley. Amid concern that this may be the worst year for whooping cough since a 2005 outbreak killed eight infants in California, health officials are recommending a new strategy to protect babies too young for vaccination. Read the full article »